1.
ABOUHUSSEIN D, TEAIMA MH, AL-NUSEIRAT A, BADARY O, EL-NABARAWI MA, EL-MONEM RA. FORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT. Int J App Pharm [Internet]. 2022 Sep. 7 [cited 2024 Nov. 25];14(5):105-12. Available from: https://mail.innovareacademics.in/journals/index.php/ijap/article/view/44289